These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8093314)

  • 1. LDL-apheresis with dextran sulphate and anaphylactoid reactions to ACE inhibitors.
    Keller C; Grützmacher P; Bahr F; Schwarzbeck A; Kroon AA; Kiral A
    Lancet; 1993 Jan; 341(8836):60-1. PubMed ID: 8093314
    [No Abstract]   [Full Text] [Related]  

  • 2. LDL apheresis with dextran sulfate and angiotension receptor antagonist (Losartan).
    Elicio N; Bertolini S; Garbarini R; Nardiello G; Elicio A; Aimale V
    Artif Organs; 1997 Apr; 21(4):334-5. PubMed ID: 9096809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibitors and LDL-apheresis with dextran sulphate adsorption.
    Kroon AA; Mol MJ; Stalenhoef AF
    Lancet; 1992 Dec; 340(8833):1476. PubMed ID: 1360599
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heparin-induced extracorporeal LDL precipitation and ACE inhibitors].
    Schuff-Werner P; Eisenhauer T; Rexer H
    Dtsch Med Wochenschr; 1993 Nov; 118(45):1665-6. PubMed ID: 8223230
    [No Abstract]   [Full Text] [Related]  

  • 5. Anaphylactoid reactions during dextran apheresis may occur even in the absence of ACE-inhibitor administration.
    Schwarzbeck A; Hilgenfeldt U; Riester U; Rambausek M; Kiral A
    Nephrol Dial Transplant; 1997 May; 12(5):1083-4. PubMed ID: 9175084
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE inhibitors.
    Olbricht CJ; Schaumann D; Fischer D
    Lancet; 1992 Oct; 340(8824):908-9. PubMed ID: 1357312
    [No Abstract]   [Full Text] [Related]  

  • 7. Establishing low-density lipoprotein apheresis tolerability in patients with prior anaphylactoid reactions to lipoprotein apheresis using magnesium sulfate.
    Alexander E; Moriarty PM; Wilk B; Eliaz I
    J Clin Apher; 2021 Jun; 36(3):437-442. PubMed ID: 33599029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anion-blood contact reaction (ABC reaction) in patients treated by LDL apheresis with dextran sulfate-cellulose column while receiving ACE inhibitors.
    Agishi T
    JAMA; 1994 Jan; 271(3):195-6. PubMed ID: 7695665
    [No Abstract]   [Full Text] [Related]  

  • 9. Anaphylactoid reactions, angiotensin-converting enzyme inhibitors and extracorporeal hemotherapy.
    Schwarzbeck A; Wittenmeier KW; Hällfritzsch U
    Nephron; 1993; 65(3):499-500. PubMed ID: 8290016
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis.
    Owen HG; Brecher ME
    Transfusion; 1994 Oct; 34(10):891-4. PubMed ID: 7940662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylactoid-like reactions in a patient with HyperLp(a)lipidemia undergoing LDL apheresis with dextran sulfate adsorption and herbal therapy with the spice turmeric.
    Adamski J; Jamensky L; Ross J; Siegel DL; Sachais BS
    J Clin Apher; 2010; 25(6):354-7. PubMed ID: 20806416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of losartan on blood pressure and humoral factors in a patient who suffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis.
    Kojima S; Shida M; Takano H; Inami S; Yodogawa K; Yokoyama H; Kuramochi M
    Hypertens Res; 2001 Sep; 24(5):595-8. PubMed ID: 11675956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation by LDL-apheresis using dextran sulphate.
    Pascual M; Blanc E; Schifferli JA
    Nephrol Dial Transplant; 1995; 10(8):1475-6. PubMed ID: 8538956
    [No Abstract]   [Full Text] [Related]  

  • 14. Unmasking hypotension by beta lactam during dextran sulfate low-density lipoprotein apheresis.
    Takenaka T; Sakamoto M; Suzuki H
    Am J Kidney Dis; 2004 Dec; 44(6):e107-8. PubMed ID: 15558512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylactoid reactions and bradykinin generation in patients treated with LDL-apheresis and an ACE inhibitor.
    Koga N; Nagano T; Sato T; Kagasawa K
    ASAIO J; 1993; 39(3):M288-91. PubMed ID: 8268545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryofiltration apheresis and plasma fractionation causing anaphylactoid reactions in patients receiving angiotensin converting enzyme inhibitors.
    Siami GA; Siami FS; Morrow JD; Stone WJ
    Ther Apher; 1997 Nov; 1(4):325-9. PubMed ID: 10225724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowering Low-Density Lipoprotein Particles in Plasma Using Dextran Sulphate Co-Precipitates Procoagulant Extracellular Vesicles.
    Wang JW; Zhang YN; Sze SK; van de Weg SM; Vernooij F; Schoneveld AH; Tan SH; Versteeg HH; Timmers L; Lam CSP; de Kleijn DPV
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein apheresis: plasma exchange or dextran sulfate adsorption apheresis.
    Yavasoglu I; Kadikoylu G; Bolaman Z
    Ther Apher Dial; 2008 Feb; 12(1):100-1; author reply 102. PubMed ID: 18257822
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of losartan in FH patients during treatment with DSC-LDL apheresis.
    Pintus S; Pintus P; Maxia P; Anedda S
    J Clin Apher; 1997; 12(3):156. PubMed ID: 9365870
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin receptor antagonists during dextran sulfate LDL-apheresis are safe.
    Sinzinger H; Chehne F; Ferlitsch A; Oguogho A
    Thromb Res; 2000 Oct; 100(1):43-6. PubMed ID: 11053615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.